287 related articles for article (PubMed ID: 2072661)
41. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
Kashmiri SV; Shu L; Padlan EA; Milenic DE; Schlom J; Hand PH
Hybridoma; 1995 Oct; 14(5):461-73. PubMed ID: 8575795
[TBL] [Abstract][Full Text] [Related]
42. Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617.
Wilson BS; Petrella E; Lowe SR; Lien K; Mackensen DG; Gridley DS; Stickney DR
Cancer Res; 1990 May; 50(10):3124-30. PubMed ID: 2159374
[TBL] [Abstract][Full Text] [Related]
43. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
[TBL] [Abstract][Full Text] [Related]
44. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
[TBL] [Abstract][Full Text] [Related]
45. A CDR-grafted (humanized) domain-deleted antitumor antibody.
Slavin-Chiorini DC; Kashmiri SV; Lee HS; Milenic DE; Poole DJ; Bernon E; Schlom J; Hand PH
Cancer Biother Radiopharm; 1997 Oct; 12(5):305-16. PubMed ID: 10851481
[TBL] [Abstract][Full Text] [Related]
46. An assessment of prolonged reactivity of seven monoclonal antibodies against CX-1 tumor xenografts using a hand-held gamma-detecting probe.
Nieroda CA; Siddiqi MA; Hinkle GH; Hill TL; Mojzisik C; Olsen J; Rousseau M; Gersman M; Houchens DP; Sardi A
J Invest Surg; 1989; 2(3):227-40. PubMed ID: 2487252
[TBL] [Abstract][Full Text] [Related]
47. Regional heterogeneity and complementation in the expression of the tumor-associated glycoprotein 72 epitopes in colorectal cancer.
Muraro R; Frati L; Bei R; Ficari F; Valli C; French D; Mammarella S; Caramia F; Fegiz G; Mariani-Costantini R
Cancer Res; 1991 Oct; 51(19):5378-83. PubMed ID: 1717150
[TBL] [Abstract][Full Text] [Related]
48. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.
Chrastina A; Pastoreková S; Pastorek J
Neoplasma; 2003; 50(1):13-21. PubMed ID: 12687273
[TBL] [Abstract][Full Text] [Related]
49. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules.
Schott ME; Milenic DE; Yokota T; Whitlow M; Wood JF; Fordyce WA; Cheng RC; Schlom J
Cancer Res; 1992 Nov; 52(22):6413-7. PubMed ID: 1423290
[TBL] [Abstract][Full Text] [Related]
50. Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody.
Shah SA; Gallagher BM; Sands H
J Natl Cancer Inst; 1987 Jun; 78(6):1069-77. PubMed ID: 3473248
[TBL] [Abstract][Full Text] [Related]
51. Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.
Slavin-Chiorini DC; Kashmiri SV; Schlom J; Calvo B; Shu LM; Schott ME; Milenic DE; Snoy P; Carrasquillo J; Anderson K
Cancer Res; 1995 Dec; 55(23 Suppl):5957s-5967s. PubMed ID: 7493377
[TBL] [Abstract][Full Text] [Related]
52. Biodistribution and histological localization of anti-human colon cancer monoclonal antibody (MAb) 1A3: the influence of administered MAb dose on tumor uptake.
Fenwick JR; Philpott GW; Connett JM
Int J Cancer; 1989 Dec; 44(6):1017-27. PubMed ID: 2691405
[TBL] [Abstract][Full Text] [Related]
53. Studies concerning the effect of external irradiation on localization of radiolabeled monoclonal antibody B72.3 to human colon carcinoma xenografts.
Shrivastav S; Schlom J; Raubitschek A; Molinolo A; Simpson J; Hand PH
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):721-9. PubMed ID: 2921170
[TBL] [Abstract][Full Text] [Related]
54. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Edwards JA; Kopher KA; Wanek PM; Wharam MD; Order SE; Klein JL
Cancer Res; 1990 Feb; 50(3 Suppl):974s-979s. PubMed ID: 2404587
[TBL] [Abstract][Full Text] [Related]
55. Construction and evaluation of the tumor imaging properties of 123I-labeled recombinant and enzymatically generated Fab fragments of the TAG-72 monoclonal antibody CC49.
Tang Y; Yang S; Gariépy J; Scollard DA; Reilly RM
Bioconjug Chem; 2007; 18(3):677-84. PubMed ID: 17361988
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of iodine-125 CC49 monoclonal antibody in patients with colon cancer.
Cook CH; Hinkle GH; Thurston MO; Martin EW
Cancer Biother Radiopharm; 1996 Dec; 11(6):415-22. PubMed ID: 10851502
[TBL] [Abstract][Full Text] [Related]
57. Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts.
Yang FE; Brown RS; Koral KF; Clavo AC; Jackson GA; Wahl RL
Cancer Immunol Immunother; 1992; 35(6):365-72. PubMed ID: 1394341
[TBL] [Abstract][Full Text] [Related]
58. Blood kinetics, tissue distribution, and radioimaging of anti-common chronic lymphatic leukemia antigen (cCLLa) monoclonal antibody CLL2 in mice transplanted with cCLLa-bearing human leukemia cells.
Faguet GB; Agee JF; DiPiro JT
Blood; 1990 May; 75(9):1853-61. PubMed ID: 2331525
[TBL] [Abstract][Full Text] [Related]
59. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.
Gallinger S; Reilly RM; Kirsh JC; Odze RD; Schmocker BJ; Hay K; Polihronis J; Damani MT; Shpitz B; Stern HS
Cancer Res; 1993 Jan; 53(2):271-8. PubMed ID: 8417820
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
